Guizhou Chitianhua Co., Ltd. Class A

Guizhou Chitianhua Co., Ltd. Class A

SSSE:600227
3.03
CNY
-0.02
(-0.66%)
-0.06EPS
6.50BMarket Cap
Guizhou Chitianhua Co., Ltd. Class A
SSE:600227
(Shanghai Stock Exchange)

Recent

price

3.03

P/E

ratio

- -

div

yld

0.86%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.44
2.07
3.68
4.38
3.46
2.09
1.74
0.97
1.41
1.2
1.14
1.29
1.49
1.33
1.41
1.28
1.54
Revenue per Share
0.14
0.1
0.04
0.01
-0.6
0.09
-0.26
0.02
0.11
-1.01
0.03
-0.03
-0.22
-0.07
-0.05
-0.16
-0.06
Basic EPS, GAAP
-1.34
-0.75
0.16
-0.06
0.21
- -
-0.11
-0.19
0.21
0.02
0.09
0.04
-0.15
0.06
0.12
0.15
- -
Free Cash Flow per Basic Share
0.36
0.33
0.35
0.24
0.21
0.17
0.09
0.04
0.03
0.03
0.02
0.01
0.01
0.03
0.03
0.03
0.03
Dividend per Share
3.51
3.61
3.63
3.7
3
3.23
2.67
2.67
2.87
1.86
1.89
1.86
1.64
1.56
1.51
1.34
1.36
Book Value per Share
3.49
3.59
3.47
3.54
2.84
3.08
2.59
2.58
2.61
1.64
1.66
1.63
1.42
1.34
1.29
1.13
0.83
Tangible Book Value per Share
921
947
951
949
950
1,409
1,571
1,740
1,729
1,693
1,695
1,695
1,693
1,694
1,693
1,689
1,682
Basic Weighted Avg Shares
1,329
1,961
3,504
4,159
3,287
2,947
2,732
1,693
2,431
2,026
1,927
2,181
2,517
2,246
2,380
2,164
2,590
Sales/Revenue/Turnover
9.17
8.25
0.25
2.07
-12.6
2.22
-2.32
3.8
15.89
3.36
11.46
3.2
-6.24
-6.69
0.28
-4.39
0.31
Operating Margin (%)
89
51
241
291
290
322
314
285
285
263
172
179
178
196
231
246
- -
Depreciation Expense
125
93
35
7
-575
128
-412
37
197
-1,710
56
-52
-367
-119
-87
-276
-95
Net Income, GAAP
19.85
24.78
- -
66.84
- -
14.69
- -
46.38
16.58
- -
11.3
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
9.43
4.74
1.01
0.18
-17.49
4.34
-15.09
2.17
8.12
-84.38
2.89
-2.38
-14.56
-5.31
-3.64
-12.75
-3.68
Profit Margin (%)
2,261
293
304
-444
-984
-1,492
-165
97
203
202
263
228
-99
-761
-746
-870
-737
Working Capital
4,554
4,444
2,987
2,212
1,546
794
334
429
175
103
92
122
409
495
487
468
441
LT Debt
3,911
4,003
3,562
3,615
3,023
3,252
4,639
4,638
4,860
3,155
3,208
3,148
2,776
2,649
2,545
2,270
2,301
Total Equity
1.46
1.06
- -
0.17
- -
2.38
- -
0.42
3.99
- -
1.99
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
1.55
1.08
- -
1.06
- -
4.3
- -
1.2
4.58
- -
2.33
- -
- -
- -
- -
- -
- -
Return on Capital (%)
4.64
2.74
1.03
0.21
-18.04
4.32
-10.69
0.79
4.16
-42.73
1.75
-1.64
-12.39
-4.4
-3.34
-11.46
-3.97
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
677
735
664
LT Borrowings
468
441
441
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,689
1,689
1,689
Market Capitalization
6,654
4,120
6,502

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
694
738
796
Cash, Cash Equivalents & STI
267
328
365
Accounts Receivable, Net
43
39
36
Inventories
238
219
238
Total Current Liabilities
1,544
1,506
1,533
Payables & Accruals
- -
- -
- -
ST Debt
677
735
664
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1.9%
-6.6%
-10.8%
Free Cash Flow
300.12%
-103.91%
16.23%
Net Income, GAAP
-62.63%
107.39%
218.27%
Sales/Revenue/Turnover
-0.86%
2.94%
-9.08%
Total Cash Common Dividend
-7.88%
15.48%
-7.14%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
437
630
637
676
2,380
2025
565
565
- -
595
2,164
2026
596
737
662
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.02
- -
- -
-0.03
-0.05
2025
-0.03
- -
- -
-0.07
-0.16
2026
-0.02
0.04
-0.01
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.03
2025
0.01
0.01
- -
0.01
0.03
2026
0.01
0.01
0.01
- -
- -
Business
Guizhou Chitianhua Co., Ltd. (600227.SS) operates as a China-based enterprise primarily engaged in chemical manufacturing, pharmaceuticals, medical services, and coal production; its core products include urea fertilizers, synthetic ammonia, ammonium products, methanol, compound fertilizers, anthracite, and thermal coal; pharmaceutical offerings encompass drugs for diabetes, cardiovascular, dermatology, gynecological, digestive, endocrine, and psychotropic conditions, alongside Chinese and Western patent medicines, medical equipment, class II clinical laboratory analysis instruments, sanitary products, and health care items. The company, formerly known as Guizhou Salvage Pharmaceutical Co., Ltd., maintains headquarters in Guizhou Province, China, where it ranks as a major nitrogen fertilizer and methanol producer, with operations centered in domestic markets and supported by coal washing, technology transfer, import-export activities, and motor vehicle maintenance services. In recent developments, its wholly-owned subsidiary Tongzi Chemical completed a planned 35-day maintenance shutdown on September 25, 2025, and resumed normal production operations, reflecting ongoing efforts to optimize chemical facility performance amid its dual focus on coal chemicals and big health industries.